Wildflower Brands Inc.

OTC: WLDFF · Healthcare · Drug Manufacturers - Specialty & Generic

Canadian filerHQ Vancouver, BCReports USD

#693 of 1,394 Healthcare companies by revenuetop-decile growth

EA Score

——

FH —DQ —GM —SS 24

v0.1 · 5/100 weight · pillars only

↑ revenue growth (YoY), Piotroski F · ↓ market scale, disclosure history

Methodology →

Revenue TTM

$14.5M

Rev growth YoY (TTM)

+318.7%

Net income (FY)

-$3.7M

Employees

Market cap

$1.4k

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Revenue$5.4M7.1M CAD2019

Net income-$3.7M-5.0M CAD2019

Operating income-$1.8M-2.4M CAD2019

Total assets$45.7M59.8M CAD2019

Liabilities$9.7M12.7M CAD2019

Equity$36.0M47.0M CAD2019

Revenue trend

FY2017 – FY2019 · USD

$83.0k

FY17

$1.1M

FY18

$5.4M

FY19

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

Wildflower Brands Inc. booked $5.4M in FY2019 revenue, growing 383% year over year — faster than 93% of Healthcare companies we track, at a -69.9% net margin.

Peers · Healthcare

Avitar, Inc.——Oracle Healthcare Acquisition Corp.——Applied Biosciences Corp.——Yulong Eco-Materials Limited——

Key facts

CEOStephen W. Pearce

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

HeadquartersVancouver, BC

ExchangeOTC: WLDFF

Employees7

IPO date2017-01-27

Latest filings

No filings loaded — no CIK (non-SEC filer).

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.